EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Clinical significance of methyl-CpG binding protein 2 in postherpetic neuralgia: an observational study

Zhijian Wang, Wei Shen, Mengye Zhu, Mu Xu, Mizhen Qiu, Daying Zhang, Shibiao Chen

Investigación Clínica · 2022

DOI: 10.54817/ic.v63n1a07 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigación Clínica, 2022. Verfasst von Zhijian Wang und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study was aimed to investigate the clinical significance of methyl-CpG binding protein 2 (MECP2) in patients with postherpetic neuralgia (PHN). This prospective case control study enrolled 319 cases of PHN patients from April 2017~December 2019. The patients’ sleep quality and quality of life were evaluated using the Pittsburgh sleep quality score and the SF-36 scale, respectively. The serum levels of MECP2, CRP, IL-6 and TNF-α were tested using enzyme linked immunosorbent assay (ELISA). The pain condition of the patients was evaluated using the visual analogue scale (VAS). The levels of MECP2 were significantly increased in PHN patients compared with the patients without PHN. Serum MECP2 levels were the highest in patients with severe pain, and were the lowest in patients with mild pain. Similarly, the frequency of severe pain in patients with low expression of MECP2 was significantly lower than the patients with higher MECP2 expression. Besides, serum levels of inflammatory factors CRP, IL-6 and TNF-α were markedly increased in PHN patients, which were also increased with the increase of the severity of pain. CRP, IL-6 and TNF-α were positively correlated with serum levels of MECP2 in PHN patients. Before the study, patients with lower MECP2 levels showed a significantly higher SF-36 score and lower Pittsburgh and VAS scores than patients with higher levels of MECP2. However, after one month, no significant difference was found between the patients. ROC curve showed MECP2 had the potential as a diagnostic biomarker for PHN. In conclusion, higher serum MECP2 levels are associated with a more severe pain condition and increased release of inflammatory factors.

Zitieren

APA

Wang, Z., Shen, W., Zhu, M., Xu, M., Qiu, M., Zhang, D., & Chen, S. (2022). Clinical significance of methyl-CpG binding protein 2 in postherpetic neuralgia: an observational study. Investigación Clínica. https://doi.org/10.54817/ic.v63n1a07

Vancouver

Wang Z, Shen W, Zhu M, Xu M, Qiu M, Zhang D, et al. Clinical significance of methyl-CpG binding protein 2 in postherpetic neuralgia: an observational study. Investigación Clínica. 2022. doi:10.54817/ic.v63n1a07

BibTeX
@article{Wang2022,
  author = {Wang, Zhijian and Shen, Wei and Zhu, Mengye and Xu, Mu and Qiu, Mizhen and Zhang, Daying and Chen, Shibiao},
  title = {Clinical significance of methyl-CpG binding protein 2 in postherpetic neuralgia: an observational study},
  journal = {Investigación Clínica},
  year = {2022},
  doi = {10.54817/ic.v63n1a07}
}
Kostenlos starten →